Cheryl Baker - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Cheryl Baker

Showing results (11-20 of 17) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 17 results.

American Journal of Clinical Oncology|October 24, 2002

Phase I clinical trial of irinotecan with oral capecitabine in patients with gastrointestinal and other solid malignanciesSanjay Goel, Minaxi Jhawer, Lakshmi Rajdev, et al.

Oncogene|March 6, 2003

Inhibition of constitutive NF-kappa B activity by I kappa B alpha M suppresses tumorigenesisShuichi Fujioka, Guido M Sclabas, Christian Schmidt, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2002

Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 productionPaul Sweeney, Takashi Karashima, Sun-Jin Kim, et al.

International Journal of Cancer|July 5, 2016

Leiodermatolide, a novel marine natural product, has potent cytotoxic and antimitotic activity against cancer cells, appears to affect microtubule dynamics, and exhibits antitumor activityEsther A Guzmán, Qunli Xu, Tara P Pitts, et al.

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 28, 2005

Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT)Patrick D Brophy, Michael J G Somers, Michelle A Baum, et al.

Kidney International|January 28, 2005

Pediatric patients with multi-organ dysfunction syndrome receiving continuous renal replacement therapyStuart L Goldstein, Michael J G Somers, Michelle A Baum, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2002

Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatinRoy S Herbst, Nizar A Mullani, Darren W Davis, et al.

Pageof 2

Search research articles

Showing results (11-20 of 17) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 17 results.

American Journal of Clinical Oncology|October 24, 2002

Phase I clinical trial of irinotecan with oral capecitabine in patients with gastrointestinal and other solid malignanciesSanjay Goel, Minaxi Jhawer, Lakshmi Rajdev, et al.

Oncogene|March 6, 2003

Inhibition of constitutive NF-kappa B activity by I kappa B alpha M suppresses tumorigenesisShuichi Fujioka, Guido M Sclabas, Christian Schmidt, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2002

International Journal of Cancer|July 5, 2016

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 28, 2005

Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT)Patrick D Brophy, Michael J G Somers, Michelle A Baum, et al.

Kidney International|January 28, 2005

Pediatric patients with multi-organ dysfunction syndrome receiving continuous renal replacement therapyStuart L Goldstein, Michael J G Somers, Michelle A Baum, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2002

Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatinRoy S Herbst, Nizar A Mullani, Darren W Davis, et al.

Pageof 2